Biodesix, Inc. (BDSX)
USD 1.34
(-3.6%)
USD 1.34
(-3.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 49.08 Million | 38.21 Million | 54.5 Million | 45.55 Million | 24.55 Million | 20.43 Million |
| Cost of Revenue | 13.01 Million | 14.15 Million | 30.51 Million | 21.99 Million | 6.07 Million | 4.4 Million |
| Gross Profit | 36.07 Million | 24.05 Million | 23.98 Million | 23.55 Million | 18.47 Million | 16.02 Million |
| Operating Expenses | 77.41 Million | 74.56 Million | 63.3 Million | 45.67 Million | 41.1 Million | 34.08 Million |
| Selling, General and Administrative Expenses | 67.38 Million | 61.46 Million | 50.51 Million | 34.85 Million | 30.63 Million | 25.89 Million |
| Research and Development Expenses | 9.98 Million | 13.1 Million | 12.78 Million | 10.81 Million | 10.46 Million | 8.18 Million |
| Other Expenses | 44 Thousand | 109 Thousand | -9000.00 | 422 Thousand | -2.37 Million | -1.23 Million |
| Cost and Expenses | 90.42 Million | 88.71 Million | 93.82 Million | 67.67 Million | 47.17 Million | 38.49 Million |
| Operating Income | -41.34 Million | -50.5 Million | -39.31 Million | -22.11 Million | -22.62 Million | -23.46 Million |
| Interest Expense | 9.53 Million | 8.07 Million | 4.5 Million | 7.6 Million | 3 Million | 2.91 Million |
| Income Tax Expense | - | 14.94 Million | 1.32 Million | 5.12 Million | 629 Thousand | 211 Thousand |
| Earnings before Tax | -52.14 Million | -65.44 Million | -43.15 Million | -31.35 Million | -30.72 Million | -26.16 Million |
| Net Income | -52.14 Million | -80.38 Million | -44.48 Million | -36.47 Million | -31.35 Million | -26.16 Million |
| Earnings Per Share Basic | -0.64 | -1.91 | -1.63 | -1.37 | -1.23 | -0.99 |
| Earnings Per Share Diluted | -0.64 | -1.91 | -1.63 | -1.37 | -1.23 | -0.99 |
| Weighted Average Shares Outstanding | 82.11 Million | 42.1 Million | 27.36 Million | 26.56 Million | 25.49 Million | 26.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.11 Million | 42.1 Million | 27.36 Million | 26.56 Million | 25.49 Million | 26.54 Million |
| Gross Margin | 0.73 | 0.63 | 0.44 | 0.52 | 0.75 | 0.78 |
| EBIT Margin | -0.76 | -1.32 | -0.72 | -0.48 | -0.90 | -0.86 |
| Profit Margin | -1.06 | -2.10 | -0.82 | -0.80 | -1.28 | -1.28 |
| EBITDA | -37.1 Million | -53.77 Million | -35.47 Million | -20.84 Million | -24.92 Million | -21.51 Million |
| Earnings Before Tax Margin | -0.84 | -1.32 | -0.72 | -0.49 | -0.92 | -1.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 18.15 Million | 17.92 Million | 14.81 Million | 49.08 Million | 14.66 Million | 13.49 Million |
| Cost of Revenue | 4.17 Million | 3.87 Million | 3.17 Million | 15.87 Million | 3.37 Million | 3.22 Million |
| Gross Profit | 13.97 Million | 14.04 Million | 11.64 Million | 33.21 Million | 11.29 Million | 10.26 Million |
| Operating Expenses | 26.74 Million | 22.21 Million | 22.59 Million | 74.5 Million | 18.14 Million | 17.43 Million |
| Selling, General and Administrative Expenses | 20.01 Million | 19.66 Million | 20.55 Million | - | 16.25 Million | 15.49 Million |
| Research and Development Expenses | 2.54 Million | 2.55 Million | 2.04 Million | - | 1.88 Million | 1.93 Million |
| Other Expenses | 4.17 Million | -387 Thousand | -64 Thousand | 6000.00 | 2000.00 | 2000.00 |
| Cost and Expenses | 26.74 Million | 26.09 Million | 25.77 Million | 90.38 Million | 21.51 Million | 20.66 Million |
| Operating Income | -8.59 Million | -8.17 Million | -10.95 Million | -41.29 Million | -6.84 Million | -7.17 Million |
| Interest Expense | -2.04 Million | 1.93 Million | 2.52 Million | 9.53 Million | 2.32 Million | 2.38 Million |
| Income Tax Expense | -1.41 Million | - | 1.27 Million | 5.33 Million | -3.23 Million | 2.38 Million |
| Earnings before Tax | -10.25 Million | -10.8 Million | -13.61 Million | -52.14 Million | -9.13 Million | -10.94 Million |
| Net Income | -10.25 Million | -10.8 Million | -13.61 Million | -52.14 Million | -9.13 Million | -10.94 Million |
| Earnings Per Share Basic | -0.07 | -0.08 | -0.14 | - | -0.10 | -0.14 |
| Earnings Per Share Diluted | -0.07 | -0.08 | -0.14 | - | -0.10 | -0.14 |
| Weighted Average Shares Outstanding | 146.29 Million | 127.16 Million | 97.16 Million | 82.11 Million | 92.32 Million | 79.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 146.29 Million | 127.16 Million | 97.16 Million | 82.11 Million | 92.32 Million | 79.7 Million |
| Gross Margin | 0.77 | 0.78 | 0.79 | 0.68 | 0.77 | 0.76 |
| EBIT Margin | -0.47 | -0.38 | -0.65 | - | -0.38 | -0.53 |
| Profit Margin | -0.57 | -0.60 | -0.92 | -1.06 | -0.62 | -0.81 |
| EBITDA | -8.59 Million | -6.85 Million | -9.63 Million | - | -5.54 Million | -7.17 Million |
| Earnings Before Tax Margin | -0.47 | -0.46 | -0.74 | -0.84 | -0.47 | -0.53 |
CNLHP
6066
RFHRF
NOW
VCSA
ALTME